NCT04838535

Brief Summary

This study intends to collect about 150 cases of follicular fluid samples from PCOS and non-PCOS infertility patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) cycles (in clinical routines).We tend to detect Raman metabolic profile of the follicular fluid of the PCOS and non-PCOS groups, and find the correlation between the metabolic profile of the follicular fluid of PCOS patients and the oocyte quality, IVF outcome and subsequent embryo development are also under investigation. Metabolomics analysis was applied to look for markers of follicular fluid in PCOS patients, and further exploring data and strategies to improve the embryonic development potential and IVF outcome of PCOS patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2019

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 3, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2021

Completed
Last Updated

April 9, 2021

Status Verified

April 1, 2021

Enrollment Period

2 years

First QC Date

April 3, 2021

Last Update Submit

April 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference between polycystic ovary syndrome and normal follicular fluids

    Raman spectrum was applied and the Raman spectrum characteristic absorption peak can be revealed. PCA analysis was used to measure the degree of differential shifts.

    24 months

Study Arms (1)

PCOS follicular fluid

OTHER
Diagnostic Test: Raman spectrum

Interventions

Raman spectrumDIAGNOSTIC_TEST

The wavelength of the follicular fluids were scaned by Raman spectrum

PCOS follicular fluid

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients fit the Rotterdam criteria for PCOS
  • Patients under IVF cycles

You may not qualify if:

  • Patients with male factors infertility
  • Patients with fallopian tube factors infertility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai JiAi Genetics and IVF Institute

Shanghai, Shanghai Municipality, 200011, China

RECRUITING

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Xiaoxi Sun, Prof.

    Shanghai JiAi Genetics & IVF Institute

    STUDY CHAIR
  • Jing Fu, Dr.

    Shanghai JiAi Genetics & IVF Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2021

First Posted

April 9, 2021

Study Start

June 19, 2019

Primary Completion

June 19, 2021

Study Completion

December 19, 2021

Last Updated

April 9, 2021

Record last verified: 2021-04

Locations